Global Continuous Renal Replacement Therapy (CRRT) Market is Expected to grow at a CAGR of ~7-9% by 2027

Growing prevalence of acute kidney injury (AKI), the rising geriatric population, the growing occurrence of sepsis, and the growing clinical advantage of continuous renal replacement therapy over intermittent blood purification are some of the crucial factors driving the global continuous renal replacement therapy (CRRT) market.

(firmenpresse) - CRRT is a slow and gentle method of dialysis that removes excess fluids and waste products from the blood in a continuous basis, much like the kidneys function in healthy individuals.

Adoption of CRRT for the Treatment of Critically ill Patients with Acute Kidney Injury (AKI) Drives Demand in Continuous Renal Replacement Therapy (CRRT) Market
Acute Kidney Injury (AKI) is a global problem and is common amongst critically ill patients. It is estimated that 13.3 million people globally are affected by AKI every year, ~85% of which live in developing nations. The goals of CRRT for critically ill patients with AKI include maintaining fluid, electrolyte, acid-base, and solute balance, supporting renal recovery, and allowing other supportive interventions to proceed without complication or limitation.

Advantages Associated with CRRT Drives the Continuous Renal Replacement Therapy (CRRT) Market Growth
Critically ill patients with AKI undergoing Renal Replacement Therapy (RRT) often experience frequent episodes of hemodynamic instability. CRRT may have a better hemodynamic profile compared with other intermittent therapies, including intermittent hemodialysis (IHD) and sustained low-efficiency dialysis. Among the CRRT’s advantages, compared to other RRT, is preventing changes in intracerebral water. CRRT is also considered safer than IHD in patients at risk of cerebral edema.
Increasing Awareness Regarding Kidney Health & Prevention Program Drives the Continuous Renal Replacement Therapy (CRRT) Market
Presently, a large number of kidney health & prevention programs are run by organizations such as National Kidney Foundation (NKF), The National Kidney Disease Education Program (NKDEP), and local governments worldwide to raise awareness regarding evidence-based interventions to improve understanding, detection, and management of kidney disease.

For instance,

?In September 2022, Fresenius Medical Care, announced they have signed a memorandum of understanding (MoU) with the National Kidney Foundation (NKF) Malaysia, this collaboration is to join efforts in raising awareness about kidney health and the prevention of chronic kidney disease amongst children and their families in Malaysia



Covid-19 Impact on the Continuous Renal Replacement Therapy (CRRT) Market
The global healthcare systems have faced significant challenges due to the COVID-19 pandemic. Among the patients hospitalized with COVID-19, a considerable proportion, ranging from 15% to 30%, exhibited signs of kidney failure and required Continuous Renal Replacement Therapy (CRRT). In these instances, CRRT acted as a life-sustaining and life-saving therapy.

Key Constraints of the Continuous Renal Replacement Therapy (CRRT) Market
The high cost of the CRRT procedures and the risk & complications associated with the CRRT such as catheter-related complications, blood loss, infection or access failure, fluctuations in salt balance, hemodialysis-related complications, coagulopathy, and venous thrombosis are likely to hinder the growth of the continuous renal replacement therapy market in the coming years.

North America Expected to Continue to Hold a large Share in the Continuous Renal Replacement Therapy (CRRT) Market
From a geographical outlook, North America holds a major market share of the continuous renal replacement therapy market. This can be primarily attributed to the growing incidences of AKI, technological advancements in continuous renal replacement therapy products, and an increase in the number of diabetic patients in North America.

Competitive Landscape Analysis of the Continuous Renal Replacement Therapy (CRRT) Market
Some of the key companies operating in the market include Baxter, B. Braun, Fresenius Medical Care AG, Medtronic, and Nipro Corporation, among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market
Companies operating in this market are adopting organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner market share.

Such as,

?In August 2022, Fresenius Medical Care closed a three-way merger including Fresenius Health Partners, the value-based care division of Fresenius Medical Care North America, and created a premier value-based kidney care provider in the U.S

?In April 2022, Baxter International Inc. announced the U.S. FDA 510(k) clearance of the company’s ST Set used in continuous renal replacement therapy (CRRT)
Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: Prathamesh
Datum: 30.07.2023 - 16:44 Uhr
Sprache: Deutsch
News-ID 2056988
Anzahl Zeichen: 5092

Kontakt-Informationen:
Ansprechpartner: Prathamesh Medi Tech
Stadt:

Brussels

Telefon: 0498868079

Kategorie:

Gesundheitswesen - Medizin

Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 30.07.2023

Diese Pressemitteilung wurde bisher 681 mal aufgerufen.

Growing Focus on Augmented Reality Spurs 13% CAGR in Global Bionic Contact Lense ...

Bionic contact lenses are an innovative blend of traditional contact lenses and advanced tech, promising to reshape vision correction and AR experiences by overlaying digital information in real time. They offer benefits such as addressing nearsighte ...

The Bioburden Testing Market Continues Upward Trend with a Projected 12-15% CAGR ...

Bioburden testing, an essential quality control process in pharmaceutical and medical device production, evaluates microbial contamination levels on products, raw materials, and manufacturing settings, including bacteria, fungi, yeasts, and molds. Th ...

The Cardiac Resuscitation Devices Market is Poised to achieve a CAGR of 6-7% by ...

Cardiopulmonary resuscitation (CPR), another name for cardiac resuscitation, is an emergency treatment given to people who are experiencing cardiac arrest—a condition in which the heart stops beating efficiently—in an emergency. In order to susta ...

Alle Meldungen von Medi-tech insights